News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read ArticleResearch Tip Sheet: Knee Arthritis, In-Hospital Addiction Help
June 12, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants
March 23, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research supported in part by NCATS. The study of a potential treatment for the condition, known as bronchopulmonary dysplasia, appears in The New England Journal of Medicine.
Ketogenic Diet Leads to Cognitive Improvement in Patients with Mild Alzheimer’s Disease
March 22, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
CTSA Program-supported researchers tested the hypothesis that ketones could provide a new source of energy for the brain in people with Alzheimer’s disease (AD). The study found improved brain function in people with mild AD after a three-month ketogenic diet.
NCATS-Supported Research Reduces Time to Diagnosis for Seriously Ill Children with Genetic Diseases
March 11, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
NCATS-supported researchers have developed an automated approach to diagnosis of genetic diseases in seriously ill children to allow faster diagnosis and initiation of treatment, and, ultimately, better outcomes. The study appeared in the April 24, 2019, issue of Science Translational Medicine.
NIH-Funded Study Suggests COVID-19 Increases Risk of Pregnancy Complications
February 7, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Pregnant women with COVID-19 appear to be at greater risk for common pregnancy complications — in addition to health risks from the virus — than pregnant women without COVID-19, suggests a study funded by NIH. The study, supported in part by NCATS, included nearly 2,400 pregnant women infected with SARS-CoV-2 and found that those with moderate to severe infection were more likely to have a cesarean delivery, to deliver preterm, to die around the time of birth, or to experience serious illness from hypertensive disorders of pregnancy, postpartum hemorrhage or from infection other than SARS-CoV-2.
International Registry Reveals Risks COVID-19 Poses with Sickle Cell Disease
February 1, 2022 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
NCATS-funded CTSA Program researchers developed a collaborative registry that collects data on COVID-19 illness in people with sickle cell disease.
Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients
January 11, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Findings from NIH’s Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients trial show that convalescent plasma taken from people who had recovered from COVID-19 was not more effective than placebo in delivering clinical improvement 14 days and 28 days after treatment began for people hospitalized with COVID-19.